Advertisement

Effects of Gonadal Hormones and Contraceptive Steroids on Glucose and Insulin Metabolism

  • Paul Beck

Abstract

Considerable data have been accumulated regarding the effect of naturally-occurring and synthetic sex steroids on glucose and insulin metabolism. The studies have been performed largely to elucidate the mechanisms responsible for changes in carbohydrate metabolism during pregnancy. Initially, studying glucose tolerance in women treated with contraceptive steroids seemed to be a logical way to dissociate the effects of gonadal steroids from the metabolic effects of human placental lactogen during gestation. However, such studies have been confusing and often apparently contradictory. Yet, if the structural characteristics of the steroid compounds tested are considered, these results are basically in agreement with, rather than contradictory to, data obtained earlier in laboratory animals. If one correlates the changes in glucose or insulin metabolism with the chemical structure of the estrogen or progestin tested, it is possible to show that there are clear structure-activity relationships between the compounds tested and the results observed, which appear to be modified by the functional state of the pancreatic islet cells in the subjects tested.

Keywords

Glucose Tolerance Ethinyl Estradiol Hypoglycemic Action Intravenous Glucose Tolerance Test Insulin Metabolism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Houssay, B.A., Foglia, V.G., and Rodriguez, R.R.: Production or prevention of some types of experimental diabetes by estrogens or corticosteroids. Acta. Endoc. 17:146–164 (1954).Google Scholar
  2. 2.
    Lewis, J.T., Foglia, V.G., Rodriguez, R.R.: The effects of steroids on the incidence of diabetes in rats after subtotal pancreatectomy. Endocrinology 46:111 (1950).PubMedCrossRefGoogle Scholar
  3. 3.
    Talaat, M., Habib, Y.A., Abdel Naby, S., Hambi, H., Malek, A.Y., Ibrahim, Z.A., and Saad, A.F.: Effects of oestradiol dipropionate on the glucose tolerance and insulin sensitivity curves in normal and ovarectomized female rabbits. Arch. Int. Pharmacodyn. 2:153 (1965).Google Scholar
  4. 4.
    Talaat, M., Habib, Y.A., Higazy, A.M., Abdel Naby, S., Malek, A.Y., and Ibrahim, Z.A.: Effect of sex hormones on the carbohydrate metabolism in normal and diabetic women. Arch. Int. Pharmacodyn. 2:154 (1965).Google Scholar
  5. 5.
    Barnes, B.O., Regan, J.F., and Nelson, W.O.: Improvement in experimental diabetes following the administration of amniotin. J. Am. Med. Ass. 101:926 (1933).CrossRefGoogle Scholar
  6. 6.
    Nelson, W.O., and Overholser, M.D.: The effect of oestrogenic hormone on experimental pancreatic diabetes in the monkey. Endocrinology 20:473 (1936).CrossRefGoogle Scholar
  7. 7.
    Dalin, G., Joseph, S., and Gaunt, R.: Effect of steroid and pituitary hormones on experimental diabetes mellitus of ferrets. Endocrinology 28:840 (1941).CrossRefGoogle Scholar
  8. 8.
    Ingle, D.J.: The relationship of the diabetogenic effect of diethylstilbesterol to the adrenal cortex in the rat. Am. J. of Physiol. 138: 577 (1943).Google Scholar
  9. 9.
    Nelson, D.H., Tanney, H., Mestman, G., Geishen, V.W., and Wilson, L.D.: Potentiation of the biologic effect of administered Cortisol by estrogen treatment. J. Clin. Endoc. 23:261–265 (1963).CrossRefGoogle Scholar
  10. 10.
    Foglia, V.G., Schuster, N., and Rodriguez, R.R.: Sex and diabetes. Endocrinology 41:428 (1947).PubMedCrossRefGoogle Scholar
  11. 11.
    Landon, J., Wynn, V., Cooke, J.N.C., and Kennedy, A.: Effects of anabolic steroid methandienone on carbohydrate metabolism in man. Metabolism 11:501–512 (1962).PubMedGoogle Scholar
  12. 12.
    Ingle, D.J., Beary, D.F., and Purmalis, A.: Comparison of effect of progesterone and 11-ketoprogesterone upon glycosuria of partially depancreatized rat. Proc. Soc. E.B. Med. 82:416- 419 (1953).Google Scholar
  13. 13.
    Benjamin, F., and Casper, D.J.: Alterations in carbohydrate metabolism induced by progesterone in cases of endometrial carcinoma and hyperplasia. Am. J. Ob. Gyn. 94:991–996 (1966).Google Scholar
  14. 14.
    Schreibeman, P.H.: Alterations in carbohydrate and lipid metabolism by a progestin. Diabetes 17:341 (1968).Google Scholar
  15. 15.
    Beck, P.: Progestin enhancement of the plasma insulin response to glucose in Rhesus monkeys. Diabetes (In Press)Google Scholar
  16. 16.
    Neill, J.D., Johansson, E.D.B., and Knobil, E.: Patterns of circulating progesterone concentrations during the fertile menstrual cycle and the remainder of gestation in the Rhesus monkey. Proc. 3rd Int. Congress of Endocrinology 157–158 (1968).Google Scholar
  17. 17.
    Kendall, J.W., Jr., Liddle, G.W., Federspiehl, C.F., and Cornfield, J.: Dissociation of corticotropin — suppressing activity from the eosinpenic and hyperglycemia activities of corticosteroid analogues. J. Clin. Invest. 42:396–403 (1963).PubMedCrossRefGoogle Scholar
  18. 18.
    Fajans, S.S., Louis, L.H., and Conn, J.W.: Metabolic effects of compound S (ll-desoxy-17-hydroxy-corticosterone) in man. J. Lab. Clin. Med. 38:911–915 (1951).PubMedGoogle Scholar
  19. 19.
    Fried, J., Florey, K., Sales, E.F., Herz, J.E., Restivo, A.R., Borman, A., and Singer, F.M.: Synthesis and biological activity of 1- and 6-dehydro~9a-halo corticoids. J. Am. Chem. Soc. 77:4181–4182 (1955).CrossRefGoogle Scholar
  20. 20.
    Ringold, H.J., Mancera, O., Djerassi, C., Bowers, A., Batres, E., Martinez, H., Neceoches, E., Edwards, J., Velasco, M., Casa Cämpillo, C., and Dorfman, R.I.: A new class of potent cortical hormones. 6a-chlorocorticoids. J. Am. Chem. Soc. 80: 6464–6465 (1958).CrossRefGoogle Scholar
  21. 21.
    Liddle, G.W.,: Studies of structure-function relationships of steroids. II. The 6a-methylcorticosteroids. Metabolism 7:405–415 (1958).PubMedGoogle Scholar
  22. 22.
    Dulin, W.E., Barnes, L.E., Glenn, E.M., Lyster, S.C., and Collins, E.J.: Biologic activities of some steroids and 6α- methyl C21 steroids. Metabolism 7:398–404 (1958).PubMedGoogle Scholar
  23. 23.
    Liddle, G.W., and Fox, M.: Structure-function relationships of anti-inflammatory steroids. In Inflammation and Diseases of Connective Tissue, Mills, L.C., and Moyer, J.H. (Eds.) (Philadelphia: Saunders, 1961), 302–309.Google Scholar
  24. 24.
    Javier, Z., Gershberg, H., and Hulse, M.: Ovulating suppressants, estrogens and carbohydrate metabolism. Metabolism 17: 443–456 (1968).PubMedCrossRefGoogle Scholar
  25. 25.
    Gershberg, H., Javier, Z., and Hulse, M.; Glucose tolerance in women receiving an ovulatory suppressant. Diabetes 13: 378–382 (1964).PubMedGoogle Scholar
  26. 26.
    Beck, P., and Wells, S.A.; Plasma insulin responses to glucose in nondiabetic and subclinical diabetic women treated with oral contraceptive agents containing mestranol. (Submitted to New Eng. J. Med.)Google Scholar
  27. 27.
    Fajans, S.S., and Conn, J.W.; The early recognition of diabetes nellitus. Annals N.Y. Acad. Sci. 82:208–218 (1959).CrossRefGoogle Scholar
  28. 28.
    Kalhoff, R.K., Richardson, B.L., and Stoddard, F.J.: Defective plasma insulin response during prednisolone glucose tolerance tests in subclinical diabetic mothers of heavy infants. Diabetes 17:37–47 (1968).Google Scholar
  29. 29.
    Kalkhoff, R.K., Richardson, B.L., and Beck, P.: Relative effects of pregnancy human placental lactogen and prednisolone on carbohydrate tolerance in normal and subclinical diabetic subjects. Diabetes (In Press)Google Scholar
  30. 30.
    Kalkhoff, R.K., Schalch, D.S., Walker, J.L., Beck, P., Kipnis, D.M., and Daughaday, W.H.: Diabetogenic factors associated with pregnancy. Trans. Asso. Am. Physicians 77:270–278 (1964).Google Scholar
  31. 31.
    Burt, R.L.: Peripheral utilization of glucose in pregnancy. III. Insulin tolerance. Ob. & Gyn. 7:658–664 (1956).Google Scholar
  32. 32.
    Josimovich, J.B.: Potentiation of somatotrophic and diabetogenic effects of growth hormone by human placental lactogen (HPL). Endocrinology 78:707–714 (1966).PubMedCrossRefGoogle Scholar
  33. 33.
    di Paola, G., Pucholo, F., Robin, M., Nicholson, R., and Marti, M.: Oral contraceptives and carbohydrate metabolism. Am. J. Ob. Gyn. 101:206–216 (1968).Google Scholar
  34. 34.
    Yen, S.S.C., and Vela, D.: The effects of contraceptive steroids on carbohydrate metabolism. J. Clin. Endoc. (In Press)Google Scholar
  35. 35.
    Pyorala, K., Pyorala, T., and Lempinen, V.: Sequential oral contraceptive treatment and intravenous glucose tolerance. The Lancet ii: 776–777 (1967).CrossRefGoogle Scholar
  36. 36.
    Spellacy, W.N., Buhi, W.C., Moses, L.C., and Goldzieher, J.W.: Carbohydrate studies in long-term users of oral contraceptives. Diabetes 17:(Supp. l):344–345 (1968).Google Scholar
  37. 37.
    Spellacy, W.N., Carlson, K.L., Birk, S.A., and Schade, S.L.: Glucose and insulin alterations after one year of combination-type oral contraceptive treatment. Metabolism 17:496–501 (1968).PubMedCrossRefGoogle Scholar
  38. 38.
    Peterson, W.F., Steel, M.W., and Coyne, R.V.: Analysis of the effect of ovulatory suppressants on glucose tolerance. Am. J. Ob. Gyn. 96: 484–488 (1966).Google Scholar
  39. 39.
    Pi-Sunyer, F.X., and Oster, S.: Effect of an ovulatory suppressant on glucose tolerance and insulin secretion. Ob. & Gyn. 31:482–484 (1968).Google Scholar
  40. 40.
    Posner, N.A., Silverstone, F.A., Pomerance, W., Baumgold, D.: Oral contraceptives and intravenous glucose tolerance. I. Data noted early in treatment. Ob. & Gyn. 29: 79–86 (1967).Google Scholar
  41. 41.
    Posner, N.A., Silverstone, F.A., Pomerance, W., and Singer, N.: Oral contraceptives and intravenous glucose tolerance. II. Long term effect. Ob. & Gyn.29: 87–92 (1967).Google Scholar
  42. 42.
    Benjamin, F., and Casper, D.J.: Comparative validity of oral and intravenous glucose tolerance tests in pregnancy: A study of 144 patients tested both during pregnancy and in the nonpregnant state. Am. J. Ob. Gyn.97: 488–492 (1967).Google Scholar
  43. 43.
    McIntyre, N., Holdsworth, C.D., and Turner, D.S.: Intestinal factors in the control of insulin secretion. J. Clin. Endoc. 25:1317–1324 (1965).CrossRefGoogle Scholar
  44. 44.
    Unger, R.H., Ohneda, A., Valverde, I., Eisenstraut, A.M., and Exton, J.: Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose. J. Clin. Invest. 47: 48–65 (1968).PubMedCrossRefGoogle Scholar
  45. 45.
    Danowski, T.S., Sabeh, G., Alley, R.A., Robbins, T.J., Tsai, C.T., and Sekaran, K.: Glucose tolerance prior to and during therapy with contraceptive steroids. Clin. Pharm. & Therap. 9:223–227 (1968).Google Scholar
  46. 46.
    Starup, J., Date, J., and Deckert, T.: Serum insulin and intravenous glucose tolerance in oral contraception. Acta. Endoc. 58:537–544 (1968).Google Scholar
  47. 47.
    Goldman, J.A., Ovadia, J.L., and Eckerling, B.: Effect of progesterone on glucose tolerance in women. Israel J. Med. Sci. 4:878–882 (1968).PubMedGoogle Scholar
  48. 48.
    Beck, P., Ohaver, S.R., and Bestley, K.J.: Unpublished results.Google Scholar
  49. 49.
    Hailing, G.R., Michals, E.L., and Paulsen, C.A.: Glucose intolerance during ethynodiol diacetate-mestranol therapy. Metabolism 16:465–468 (1967).CrossRefGoogle Scholar
  50. 50.
    Wynn, V., Doar, J.W.H., and Mills, G.L.: Some effects of oral contraceptives on serum-lipid and lipoprotein levels. The Lancet, II: 720–723 (1966).CrossRefGoogle Scholar
  51. 51.
    Jackson, L.A., and Clark, J.F.J.: The effect of steroids on the glucose metabolism of non-pregnant diabetics. J. Nat. Med. Assoc. 58: 105–106 (1966).Google Scholar
  52. 52.
    Beck, P., and Daughaday, W.H.: Human placental lactogen: Studies of its acute metabolic effects and disposition in normal man. J. Clin. Invest. 46:103–110 (1967).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1969

Authors and Affiliations

  • Paul Beck
    • 1
  1. 1.Endocrinology Division, Department of Medicine, School of MedicineUniversity of ColoradoDenverUSA

Personalised recommendations